APOE DNA methylation is altered in Lewy body dementia

Jessica Tulloch, Lesley Leong, Sunny Chen, C. Dirk Keene, Steven P. Millard, Andrew Shutes-David, Oscar L. Lopez, Julia Kofler, Jeffrey Kaye, Randall (Randy) Woltjer, Peter T. Nelson, Janna H. Neltner, Gregory A. Jicha, Douglas Galasko, Eliezer Masliah, James B. Leverenz, Chang En Yu, Debby Tsuang

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Introduction: Inheritance of the ε4 allele of apolipoprotein E (APOE) increases a person's risk of developing both Alzheimer's disease (AD) and Lewy body dementia (LBD), yet the underlying mechanisms behind this risk are incompletely understood. The recent identification of reduced APOE DNA methylation in AD postmortem brains prompted this study to investigate APOE methylation in LBD. Methods: Genomic DNA from postmortem brain tissues (frontal lobe and cerebellum) of neuropathological pure (np) controls and npAD, LBD + AD, and npLBD subjects were bisulfite pyrosequenced. DNA methylation levels of two APOE subregions were then compared for these groups. Results: APOE DNA methylation was significantly reduced in npLBD compared with np controls, and methylation levels were lowest in the LBD + AD group. Discussion: Given that npLBD and npAD postmortem brains shared a similar reduction in APOE methylation, it is possible that an aberrant epigenetic change in APOE is linked to risk for both diseases.

Original languageEnglish (US)
JournalAlzheimer's and Dementia
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

Lewy Body Disease
Apolipoproteins E
DNA Methylation
Alzheimer Disease
Methylation
Brain
Apolipoprotein E4
Frontal Lobe
Epigenomics
Cerebellum
Alleles
DNA

Keywords

  • Alzheimer's disease (AD)
  • Apolipoprotein E (APOE)
  • Cerebellum
  • Dementia with Lewy bodies (DLB)
  • Differential methylation
  • Differentially methylated region (DMR)
  • DNA methylation
  • Epigenetics
  • Frontal lobe
  • Human
  • Lewy body dementia (LBD)
  • Postmortem brain
  • Pyrosequencing

ASJC Scopus subject areas

  • Epidemiology
  • Health Policy
  • Developmental Neuroscience
  • Clinical Neurology
  • Geriatrics and Gerontology
  • Cellular and Molecular Neuroscience
  • Psychiatry and Mental health

Cite this

Tulloch, J., Leong, L., Chen, S., Keene, C. D., Millard, S. P., Shutes-David, A., ... Tsuang, D. (Accepted/In press). APOE DNA methylation is altered in Lewy body dementia. Alzheimer's and Dementia. https://doi.org/10.1016/j.jalz.2018.02.005

APOE DNA methylation is altered in Lewy body dementia. / Tulloch, Jessica; Leong, Lesley; Chen, Sunny; Keene, C. Dirk; Millard, Steven P.; Shutes-David, Andrew; Lopez, Oscar L.; Kofler, Julia; Kaye, Jeffrey; Woltjer, Randall (Randy); Nelson, Peter T.; Neltner, Janna H.; Jicha, Gregory A.; Galasko, Douglas; Masliah, Eliezer; Leverenz, James B.; Yu, Chang En; Tsuang, Debby.

In: Alzheimer's and Dementia, 01.01.2018.

Research output: Contribution to journalArticle

Tulloch, J, Leong, L, Chen, S, Keene, CD, Millard, SP, Shutes-David, A, Lopez, OL, Kofler, J, Kaye, J, Woltjer, RR, Nelson, PT, Neltner, JH, Jicha, GA, Galasko, D, Masliah, E, Leverenz, JB, Yu, CE & Tsuang, D 2018, 'APOE DNA methylation is altered in Lewy body dementia', Alzheimer's and Dementia. https://doi.org/10.1016/j.jalz.2018.02.005
Tulloch J, Leong L, Chen S, Keene CD, Millard SP, Shutes-David A et al. APOE DNA methylation is altered in Lewy body dementia. Alzheimer's and Dementia. 2018 Jan 1. https://doi.org/10.1016/j.jalz.2018.02.005
Tulloch, Jessica ; Leong, Lesley ; Chen, Sunny ; Keene, C. Dirk ; Millard, Steven P. ; Shutes-David, Andrew ; Lopez, Oscar L. ; Kofler, Julia ; Kaye, Jeffrey ; Woltjer, Randall (Randy) ; Nelson, Peter T. ; Neltner, Janna H. ; Jicha, Gregory A. ; Galasko, Douglas ; Masliah, Eliezer ; Leverenz, James B. ; Yu, Chang En ; Tsuang, Debby. / APOE DNA methylation is altered in Lewy body dementia. In: Alzheimer's and Dementia. 2018.
@article{9454afd0f3b14b13a7ecfbf3682c0d66,
title = "APOE DNA methylation is altered in Lewy body dementia",
abstract = "Introduction: Inheritance of the ε4 allele of apolipoprotein E (APOE) increases a person's risk of developing both Alzheimer's disease (AD) and Lewy body dementia (LBD), yet the underlying mechanisms behind this risk are incompletely understood. The recent identification of reduced APOE DNA methylation in AD postmortem brains prompted this study to investigate APOE methylation in LBD. Methods: Genomic DNA from postmortem brain tissues (frontal lobe and cerebellum) of neuropathological pure (np) controls and npAD, LBD + AD, and npLBD subjects were bisulfite pyrosequenced. DNA methylation levels of two APOE subregions were then compared for these groups. Results: APOE DNA methylation was significantly reduced in npLBD compared with np controls, and methylation levels were lowest in the LBD + AD group. Discussion: Given that npLBD and npAD postmortem brains shared a similar reduction in APOE methylation, it is possible that an aberrant epigenetic change in APOE is linked to risk for both diseases.",
keywords = "Alzheimer's disease (AD), Apolipoprotein E (APOE), Cerebellum, Dementia with Lewy bodies (DLB), Differential methylation, Differentially methylated region (DMR), DNA methylation, Epigenetics, Frontal lobe, Human, Lewy body dementia (LBD), Postmortem brain, Pyrosequencing",
author = "Jessica Tulloch and Lesley Leong and Sunny Chen and Keene, {C. Dirk} and Millard, {Steven P.} and Andrew Shutes-David and Lopez, {Oscar L.} and Julia Kofler and Jeffrey Kaye and Woltjer, {Randall (Randy)} and Nelson, {Peter T.} and Neltner, {Janna H.} and Jicha, {Gregory A.} and Douglas Galasko and Eliezer Masliah and Leverenz, {James B.} and Yu, {Chang En} and Debby Tsuang",
year = "2018",
month = "1",
day = "1",
doi = "10.1016/j.jalz.2018.02.005",
language = "English (US)",
journal = "Alzheimer's and Dementia",
issn = "1552-5260",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - APOE DNA methylation is altered in Lewy body dementia

AU - Tulloch, Jessica

AU - Leong, Lesley

AU - Chen, Sunny

AU - Keene, C. Dirk

AU - Millard, Steven P.

AU - Shutes-David, Andrew

AU - Lopez, Oscar L.

AU - Kofler, Julia

AU - Kaye, Jeffrey

AU - Woltjer, Randall (Randy)

AU - Nelson, Peter T.

AU - Neltner, Janna H.

AU - Jicha, Gregory A.

AU - Galasko, Douglas

AU - Masliah, Eliezer

AU - Leverenz, James B.

AU - Yu, Chang En

AU - Tsuang, Debby

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Introduction: Inheritance of the ε4 allele of apolipoprotein E (APOE) increases a person's risk of developing both Alzheimer's disease (AD) and Lewy body dementia (LBD), yet the underlying mechanisms behind this risk are incompletely understood. The recent identification of reduced APOE DNA methylation in AD postmortem brains prompted this study to investigate APOE methylation in LBD. Methods: Genomic DNA from postmortem brain tissues (frontal lobe and cerebellum) of neuropathological pure (np) controls and npAD, LBD + AD, and npLBD subjects were bisulfite pyrosequenced. DNA methylation levels of two APOE subregions were then compared for these groups. Results: APOE DNA methylation was significantly reduced in npLBD compared with np controls, and methylation levels were lowest in the LBD + AD group. Discussion: Given that npLBD and npAD postmortem brains shared a similar reduction in APOE methylation, it is possible that an aberrant epigenetic change in APOE is linked to risk for both diseases.

AB - Introduction: Inheritance of the ε4 allele of apolipoprotein E (APOE) increases a person's risk of developing both Alzheimer's disease (AD) and Lewy body dementia (LBD), yet the underlying mechanisms behind this risk are incompletely understood. The recent identification of reduced APOE DNA methylation in AD postmortem brains prompted this study to investigate APOE methylation in LBD. Methods: Genomic DNA from postmortem brain tissues (frontal lobe and cerebellum) of neuropathological pure (np) controls and npAD, LBD + AD, and npLBD subjects were bisulfite pyrosequenced. DNA methylation levels of two APOE subregions were then compared for these groups. Results: APOE DNA methylation was significantly reduced in npLBD compared with np controls, and methylation levels were lowest in the LBD + AD group. Discussion: Given that npLBD and npAD postmortem brains shared a similar reduction in APOE methylation, it is possible that an aberrant epigenetic change in APOE is linked to risk for both diseases.

KW - Alzheimer's disease (AD)

KW - Apolipoprotein E (APOE)

KW - Cerebellum

KW - Dementia with Lewy bodies (DLB)

KW - Differential methylation

KW - Differentially methylated region (DMR)

KW - DNA methylation

KW - Epigenetics

KW - Frontal lobe

KW - Human

KW - Lewy body dementia (LBD)

KW - Postmortem brain

KW - Pyrosequencing

UR - http://www.scopus.com/inward/record.url?scp=85044739296&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044739296&partnerID=8YFLogxK

U2 - 10.1016/j.jalz.2018.02.005

DO - 10.1016/j.jalz.2018.02.005

M3 - Article

JO - Alzheimer's and Dementia

JF - Alzheimer's and Dementia

SN - 1552-5260

ER -